Found: 7
Select item for more details and to access through your institution.
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13109-5
- By:
- Publication type:
- Article
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 6, p. 1329, doi. 10.1002/1878-0261.13192
- By:
- Publication type:
- Article
PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50419-2
- By:
- Publication type:
- Article
Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232545
- By:
- Publication type:
- Article
Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor.
- Published in:
- FEBS Open Bio, 2023, v. 13, n. 6, p. 1056, doi. 10.1002/2211-5463.13616
- By:
- Publication type:
- Article
Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 5, p. 1607, doi. 10.1111/cas.14395
- By:
- Publication type:
- Article